Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | farnesyl diphosphate synthase | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 904 nM | Stimulation of IP3-coupled mobilization of calcium in HEK293 cells expressing MCH-R1 | ChEMBL. | 16919453 |
IC50 (binding) | = 6.6 nM | Displacement of 125I-[Phe13,Tyr19]-MCH from human MCH-R1 | ChEMBL. | 16919453 |
IC50 (binding) | = 3.57 uM | Inhibitory concentration against trypanosoma cruzi farnesyl pyrophosphate synthase (TcFPPS) | ChEMBL. | 16143525 |
IC50 (binding) | = 3.57 uM | Inhibitory concentration against trypanosoma cruzi farnesyl pyrophosphate synthase (TcFPPS) | ChEMBL. | 16143525 |
IC50 (functional) | = 72 uM | Inhibitory concentration against growth of trypanosoma cruzi amastigotes | ChEMBL. | 16143525 |
IC50 (functional) | = 72 uM | Inhibitory concentration against growth of trypanosoma cruzi amastigotes | ChEMBL. | 16143525 |
IC50 (functional) | > 100 uM | Inhibitory concentration against growth of trypanosoma cruzi epimastigotes | ChEMBL. | 16143525 |
IC50 (functional) | > 100 uM | Inhibitory concentration against growth of trypanosoma cruzi epimastigotes | ChEMBL. | 16143525 |
Inhibition (binding) | < 50 % | Inhibition of 125I-[Phe13,Tyr19]-MCH binding to human MCH-R2 at 2uM | ChEMBL. | 16919453 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.